Pharmedic Pharmaceutical Medicinal JSC (HNX:PMC)
Vietnam
· Delayed Price · Currency is VND 177,200
-7,800 (-4.22%)
At close: Dec 4, 2025
HNX:PMC Balance Sheet
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Jan '21 Jan 1, 2021 | 2020 - 2016 |
| Cash & Equivalents | 31,858 | 60,084 | 13,252 | 37,454 | 29,430 | 115,026 | Upgrade
|
| Short-Term Investments | 500 | 141,000 | 249,000 | 256,100 | 242,131 | 111,500 | Upgrade
|
| Cash & Short-Term Investments | 32,358 | 201,084 | 262,252 | 293,554 | 271,560 | 226,526 | Upgrade
|
| Cash Growth | -86.02% | -23.32% | -10.66% | 8.10% | 19.88% | 33.47% | Upgrade
|
| Accounts Receivable | 34,540 | 41,222 | 39,310 | 35,254 | 39,175 | 34,034 | Upgrade
|
| Other Receivables | 972.63 | 3,042 | 3,605 | 3,233 | 2,159 | 1,260 | Upgrade
|
| Receivables | 35,513 | 44,264 | 42,915 | 38,487 | 41,335 | 35,294 | Upgrade
|
| Inventory | 120,385 | 71,119 | 67,244 | 104,546 | 71,379 | 89,414 | Upgrade
|
| Prepaid Expenses | 4,467 | 435.06 | 453.29 | 282.38 | 915.04 | 434.98 | Upgrade
|
| Other Current Assets | 68,780 | 18,533 | 6,207 | 4,273 | 3,853 | 4,265 | Upgrade
|
| Total Current Assets | 261,503 | 335,436 | 379,071 | 441,141 | 389,042 | 355,934 | Upgrade
|
| Property, Plant & Equipment | 51,915 | 32,127 | 39,704 | 45,890 | 53,900 | 65,179 | Upgrade
|
| Other Intangible Assets | 2,043 | 2,214 | 2,443 | 2,731 | 2,991 | 3,165 | Upgrade
|
| Other Long-Term Assets | 9,229 | 6,062 | 5,157 | 4,362 | 5,560 | 4,774 | Upgrade
|
| Total Assets | 324,691 | 375,839 | 426,375 | 494,124 | 451,494 | 429,053 | Upgrade
|
| Accounts Payable | 14,738 | 16,250 | 12,730 | 15,668 | 8,378 | 12,575 | Upgrade
|
| Accrued Expenses | 42,232 | 44,572 | 46,302 | 36,141 | 38,986 | 41,184 | Upgrade
|
| Current Income Taxes Payable | 10,067 | 6,580 | 7,821 | 7,364 | 7,203 | 4,202 | Upgrade
|
| Current Unearned Revenue | 2,070 | 1,457 | 1,002 | 669.46 | 804.02 | 733.99 | Upgrade
|
| Other Current Liabilities | 18,908 | 17,369 | 15,322 | 6,500 | 7,246 | 6,184 | Upgrade
|
| Total Current Liabilities | 88,016 | 86,227 | 83,178 | 66,342 | 62,617 | 64,879 | Upgrade
|
| Total Liabilities | 88,016 | 86,227 | 83,178 | 66,342 | 62,617 | 64,879 | Upgrade
|
| Common Stock | 93,326 | 93,326 | 93,326 | 93,326 | 93,326 | 93,326 | Upgrade
|
| Additional Paid-In Capital | 972.97 | 972.97 | 972.97 | 972.97 | 972.97 | 972.97 | Upgrade
|
| Retained Earnings | 142,376 | 195,313 | 248,898 | 333,483 | 294,578 | 269,875 | Upgrade
|
| Total Common Equity | 236,675 | 289,612 | 343,197 | 427,782 | 388,877 | 364,173 | Upgrade
|
| Shareholders' Equity | 236,675 | 289,612 | 343,197 | 427,782 | 388,877 | 364,173 | Upgrade
|
| Total Liabilities & Equity | 324,691 | 375,839 | 426,375 | 494,124 | 451,494 | 429,053 | Upgrade
|
| Net Cash (Debt) | 32,358 | 201,084 | 262,252 | 293,554 | 271,560 | 226,526 | Upgrade
|
| Net Cash Growth | -86.02% | -23.32% | -10.66% | 8.10% | 19.88% | 33.47% | Upgrade
|
| Net Cash Per Share | 3467.22 | 21546.50 | 28100.75 | 31454.72 | 29098.14 | 24272.60 | Upgrade
|
| Filing Date Shares Outstanding | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | Upgrade
|
| Total Common Shares Outstanding | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | 9.33 | Upgrade
|
| Working Capital | 173,487 | 249,208 | 295,893 | 374,799 | 326,425 | 291,055 | Upgrade
|
| Book Value Per Share | 25360.08 | 31032.37 | 36774.09 | 45837.52 | 41668.77 | 39021.74 | Upgrade
|
| Tangible Book Value | 234,632 | 287,397 | 340,754 | 425,052 | 385,886 | 361,008 | Upgrade
|
| Tangible Book Value Per Share | 25141.14 | 30795.08 | 36512.36 | 45544.94 | 41348.27 | 38682.57 | Upgrade
|
| Buildings | 33,322 | 32,966 | 32,966 | 32,966 | 32,966 | 32,966 | Upgrade
|
| Machinery | 205,236 | 190,875 | 187,316 | 182,470 | 181,032 | 181,629 | Upgrade
|
| Construction In Progress | 2,418 | 68.69 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.